123 related articles for article (PubMed ID: 12799286)
1. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
Brenner MK; Wulf GG; Rill DR; Luo KL; Goodell MA; Mei Z; Kuehnle I; Brown MP; Pule M; Heslop HE; Krance RA
Ann N Y Acad Sci; 2003 May; 996():80-8. PubMed ID: 12799286
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation.
Wulf GG; Luo KL; Goodell MA; Brenner MK
Blood; 2003 Mar; 101(6):2434-9. PubMed ID: 12433683
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy.
Krance RA; Kuehnle I; Rill DR; Mei Z; Pinetta C; Evans W; Brown MP; Pulé M; Heslop HE; Brenner MK
Biol Blood Marrow Transplant; 2003 Apr; 9(4):273-81. PubMed ID: 12720220
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
Ruffner KL; Martin PJ; Hussell S; Nourigat C; Fisher DR; Bernstein ID; Matthews DC
Cancer Res; 2001 Jul; 61(13):5126-31. PubMed ID: 11431350
[TBL] [Abstract][Full Text] [Related]
5. A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
Jäger MD; Vondran FW; Ramackers W; Röseler T; Schlitt HJ; Bektas H; Klempnauer J; Timrott K
PLoS One; 2016; 11(5):e0154682. PubMed ID: 27139494
[TBL] [Abstract][Full Text] [Related]
6. Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Matthews DC; Martin PJ; Nourigat C; Appelbaum FR; Fisher DR; Bernstein ID
Blood; 1999 Jan; 93(2):737-45. PubMed ID: 9885237
[TBL] [Abstract][Full Text] [Related]
7. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.
Dahlke MH; Lauth OS; Jäger MD; Roeseler T; Timrott K; Jackobs S; Neipp M; Wonigeit K; Schlitt HJ
Blood; 2002 May; 99(10):3566-72. PubMed ID: 11986209
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of new "biologic" approaches to therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.
Sievers EL
Curr Opin Oncol; 2000 Jan; 12(1):30-5. PubMed ID: 10687726
[TBL] [Abstract][Full Text] [Related]
9. CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice.
Shivtiel S; Lapid K; Kalchenko V; Avigdor A; Goichberg P; Kalinkovich A; Nagler A; Kollet O; Lapidot T
Exp Hematol; 2011 Dec; 39(12):1161-1170.e1. PubMed ID: 21911094
[TBL] [Abstract][Full Text] [Related]
10. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
11. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
12. CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.
Wulf GG; Boehnke A; Chapuy B; Glass B; Hemmerlein B; Schroers R; Brenner MK; Truemper L
Haematologica; 2006 Jul; 91(7):886-94. PubMed ID: 16818275
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.
Yeung J; Liao A; Shaw M; Silva S; Vetharoy W; Rico DL; Kirby I; Zammarchi F; Havenith K; de Haan L; van Berkel PH; Sebire N; Ogunbiyi OK; Booth C; Gaspar HB; Thrasher AJ; Chester KA; Amrolia PJ
Mol Ther; 2024 Jun; 32(6):1672-1686. PubMed ID: 38549377
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency.
Castiello MC; Bosticardo M; Sacchetti N; Calzoni E; Fontana E; Yamazaki Y; Draghici E; Corsino C; Bortolomai I; Sereni L; Yu HH; Uva P; Palchaudhuri R; Scadden DT; Villa A; Notarangelo LD
J Allergy Clin Immunol; 2021 Jan; 147(1):309-320.e6. PubMed ID: 32387109
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Sandmaier BM
Transplantation; 2004 Aug; 78(3):352-9. PubMed ID: 15316362
[TBL] [Abstract][Full Text] [Related]
17. Assessment of lymphocyte development in radiation bone marrow chimeras.
Spangrude GJ
Curr Protoc Immunol; 2001 May; Chapter 4():4.6.1-4.6.8. PubMed ID: 18432797
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.
Orozco JJ; Bäck T; Kenoyer A; Balkin ER; Hamlin DK; Wilbur DS; Fisher DR; Frayo SL; Hylarides MD; Green DJ; Gopal AK; Press OW; Pagel JM
Blood; 2013 May; 121(18):3759-67. PubMed ID: 23471305
[TBL] [Abstract][Full Text] [Related]
19. Use of radiolabeled antibodies in the treatment of childhood acute leukemia.
Nemecek ER; Matthews DC
Pediatr Transplant; 2003; 7 Suppl 3():89-94. PubMed ID: 12603700
[TBL] [Abstract][Full Text] [Related]
20. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
